We also found that another T3SS1 effector, VopS, dampens VopQ-mediated activation of ERK1/2 signaling by AMPylation-dependent inactivation of Rho GTPases, thereby limiting the activation of ERK1/2 signaling to early infection time points. The gene discussed is MAPK3; the disease is infection.